As of 2026-09-29, the EV/EBITDA ratio of MEI Pharma Inc (MEIP) is -4.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MEIP's latest enterprise value is 91.73 mil USD. MEIP's TTM EBITDA according to its financial statements is -21.71 mil USD. Dividing these 2 quantities gives us the above MEIP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.3x - 16.2x | 15.6x |
| Forward P/E multiples | 18.6x - 21.8x | 19.3x |
| Fair Price | (11.10) - 11.38 | (0.63) |
| Upside | -461.7% - 270.6% | -120.5% |
| Date | EV/EBITDA |